Primary cutaneous Acanthamoeba infection in a patient with AIDS

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1547-1548

  Migueles, Stephen ^a   Kumar, Princy ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE; ITRACONAZOLE; KETOCONAZOLE; PENTAMIDINE ISETHIONATE; SILVER NITRATE;

ACANTHAMOEBA CASTELLANII; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FACE INJURY; HOMOSEXUALITY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN ULCER; TOPICAL DRUG ADMINISTRATION;

EID: 0032458948     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517750     Document Type: Article

References (5)

1. Slater CA, Sickel JZ, Visvesvara GS, Pabico RC, Gaspari AA. Brief report: successful treatment of disseminated acanthamoeba infection in an immunocompromised patient. N Engl J Med 1994; 331:85-7.
2. Sison JP, Kemper CA, Loveless M, McShane D, Visvesvara GS, Deresinski SC. Disseminated acanthamoeba infection in patients with AIDS: case reports and review. Clin Infect Dis 1995; 20:1207-16.
3. Murakawa GJ, McCalmont T, Altman J, et al. Disseminated acanthamebiasis in patients with AIDS. A report of five cases and a review of the literature. Arch Dermatol 1995; 131:1291-6.
4. Deluol AM, Teilhac MF, Poirot JL, et al. Cutaneous lesions due to Acanthamoeba sp in a patient with AIDS. J Eukaryot Microbiol 1996; 43:S130-1.
5. Tomlinson G. Screening for chemical inhibitors of growth rate, encystment, and excystment in Acanthamoeba castellani. Rev Infect Dis 1991; 13(suppl 5):S436-7.